Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.

In the same study, the authors analyzed the relationship between survival of ccRCC patients and PSMA expression in IHC, and observed different median OS of 37.5, 24, and 34 months in groups with low or no expression, moderate expression, and high expression of PSMA, respectively, although the results did not reach statistical significance ( p = 0.20) [ 61 ].

also in 111,027 other papers